FDA announces voluntary recall of injectables produced by Coastal Meds

FDA
After Coastal Meds didn’t make the recall public at the request of the FDA, the agency issued an alert to health care professionals. (FDA)

The FDA made public a voluntary recall of sterile injectable drugs produced by compounder Coastal Meds of Biloxi, Mississippi, after visible particles were found in some vials.

The company issued a voluntary recall in early April, however, after Coastal Meds didn’t make the recall public at the request of the FDA, the agency issued an alert to health care professionals not to use and to dispose of the products manufactured by Coastal.

During a recent inspection of the company’s facility, investigators found visible particulates and poor sterile production practices, raising concerns about particulates in Coastal’s drug products intended for injection.

To date, there have not been any reports of adverse events associated with drug products produced by Coastal. The company is registered as an outsourcing facility.

Read more on

Suggested Articles

South Korea’s Celltrion, which has a massive biologics site in Songdo, has decided it is time to build some operations in China.

WuXi Biologics is taking control of a Bayer plant in Germany and agreed it could serve as a backup facility for supply of hemophilia drug Kovaltry.

A Chinese OTC drugmaker gets the distinction of ringing in the new year as the first company to be slapped with an FDA warning letter.